Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2757)	1/31/2001 10:08:21 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 52153

Great <<``We feel we disclosed everything in a detailed fashion,'' Bell said. Although the primary goal did not appear in the first statement, Bell said Alexion officials gave a detailed explanation of the primary goals of the trial in a conference call with analysts the day the release went out. ``We fully disclosed (the data on the primary goal) in the conference call. I think we made a full disclosure with about an hour-long discussion when we exquisitely went over our data,'' Bell said.>> So finalcial industry select few heavies had a chance for they or their big clients to dump into a runnup on the general public news. This would really reprsent a red flag for the future to me (the kind of reason I'm not invested in TRIBY any longer - flagrant disregard for retail investors) The guy's either seriously insensitive towards us or dense judging by his response, thinking it's OK to just disclose to the privelaged few. IMSCO Scott